{
    "medicine_id": "57be918719e6e97acd0b9ee0d130b94f04c6602d",
    "platform_id": "DB14051",
    "metadata": {
        "name": "Lokelma 10 g 10g Powder for suspension",
        "composition": "10 g 10g Malacidin A",
        "clinical_particulars": {
            "therapeutic_indications": "Malacidin A is being investigated for its antibiotic action and has potential for use as an antibacterial agent in the future A33312",
            "contraindications": {
                "disease": "Malacidin A has no observed toxicity or haemolytic effect on mammalian cells at concentrations of up to 100 250 \u03bcg mL over 100 times the MIC for affected pathogens A33312",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Malacidin A disrupts bacterial cell wall synthesis likely leading to cell death in Gram positive bacteria A33312 This bactericidal effect reduces the number of live bacteria present during infection Malacidin A has exhibited broad spectrum activity against Gram positive bacteria including several multi drug resistant pathogens",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09268",
                        "description": "The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Malacidin A"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Malacidin A"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Malacidin A"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Malacidin A is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Malacidin A"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Malacidin A"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}